Switzerland · Who invested in Delenex Therapeutics?
Delenex Therapeutics's investors include SV Life Sciences, HBM BioVentures, VI Partners, BioMedPartners and HBM BioCapital, and 2 more on record.
201120122013
$14MSeries A$19MSeries A$8.0MSeries ASwitzerland · Series A startup
Who invested in Delenex Therapeutics
Funding summaryUpdated 26 Oct 2026
$41Mraised across 3 rounds since 2010, from 3 sources
$14MSeries A$19MSeries A$8.0MSeries A
- Latest round
- Series A, $8.0MNov 2013
- Biggest round
- $19MSeries A · May 2011
- Investors
- 7
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $14M Nov 2010
- Biggest round
- $19M Series A · May 2011
- Usual gap between rounds
- 2.5 years the median of 2
The rounds
- Nov 2013Series A$8.0M1 new4 returning
Reported by startupticker.ch
- May 2011Series A$19M1 new5 returning
Reported by finsmes.com
- Nov 2010Series A$14M5 new
Reported by finsmes.com
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series A2010Series A2011Series A2013SV Life SciencesHBM BioVentures
VI Partners
BioMedPartnersHBM BioCapital
Novo HoldingsNovo Holdings A/S
VI PartnersBioMedPartnersHBM BioCapitalNovo HoldingsNovo Holdings A/SEveryone who backed them
SV Life SciencesVC firm3rounds
HBM BioVenturesGrowth equity3rounds
HBM BioCapitalInvestment firm2rounds
Novo Holdings A/SGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Delenex Therapeutics
How much has Delenex Therapeutics raised?
Delenex Therapeutics has raised $41M across 3 rounds since 2010.
When did Delenex Therapeutics last raise?
Delenex Therapeutics's most recent round was a Series A of $8.0M in Nov 2013.
What was Delenex Therapeutics's biggest round?
Delenex Therapeutics's largest round on record is $19M (Series A), in May 2011.
Who backed Delenex Therapeutics first?
Delenex Therapeutics's first round on record, in Nov 2010, was backed by SV Life Sciences, HBM BioVentures and VI Partners and 2 others.
What stage is Delenex Therapeutics at?
Delenex Therapeutics's latest named round is a Series A, in Nov 2013.
Where is Delenex Therapeutics based?
Delenex Therapeutics is based in Switzerland.
Companies like Delenex Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.